Literature DB >> 21136957

The use of phosphate-affinity SDS-PAGE to measure the cardiac troponin I phosphorylation site distribution in human heart muscle.

Andrew E Messer1, Clare E Gallon, William J McKenna, Cristobal G Dos Remedios, Steven B Marston.   

Abstract

We have used phosphate affinity SDS-PAGE to separate the phosphorylated species of cardiac troponin I (cTnI). To test the method we phosphorylated pure cTnI with protein kinase A catalytic subunit and observed up to six bands corresponding to 0, 1P, 2P, 3P, 4P and 5P phospho-species. We examined the phospho-species of cTnI in human heart myofibrillar extracts by phosphate affinity SDS-PAGE and Western blotting with a non-specific troponin I (TnI) antibody. In donor heart samples the bis-phosphorylated species of cTnI predominated and no more highly phosphorylated species were not detectable (0P was 10.3±1.9%, 1P, 17.5±3.5%, 2P, 72.2±4.7%, 11 samples). Total phosphorylation was 1.62±0.06 molsPi/mol TnI. In myofibrils from end-stage failing hearts, the unphosphorylated cTnI species predominated (0P was 78.5±1.8%, 1P, 17.5±1.9%, 2P, 4.0±0.7%, total phosphorylation 0.26±0.02 molsPi/mol TnI, five samples). Muscle from patients with hypertrophic obstructive cardiomyopathy was also largely unphosphorylated (0P was 76.6±3.1%, 1P, 17.5±2.7%, 2P, 5.9±0.8%, total phosphorylation 0.29±0.04 molsPi/mol TnI, 19 samples). Using a range of phospho-specific antibodies we demonstrated that 3/4 of the bis-phosphorylated band of donor heart cTnI is phosphorylated at Ser22 and Ser23 in approximately equal amounts and that phosphorylation of Ser43 and Thr142 was not detected.
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2009        PMID: 21136957     DOI: 10.1002/prca.200900071

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  41 in total

1.  Preconcentration and detection of the phosphorylated forms of cardiac troponin I in a cascade microchip by cationic isotachophoresis.

Authors:  Danny Bottenus; Mohammad Robiul Hossan; Yexin Ouyang; Wen-Ji Dong; Prashanta Dutta; Cornelius F Ivory
Journal:  Lab Chip       Date:  2011-09-21       Impact factor: 6.799

2.  Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

Authors:  Xintong Dong; C Amelia Sumandea; Yi-Chen Chen; Mary L Garcia-Cazarin; Jiang Zhang; C William Balke; Marius P Sumandea; Ying Ge
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

3.  Peroxisome proliferator-activated receptor-α expression induces alterations in cardiac myofilaments in a pressure-overload model of hypertrophy.

Authors:  Chehade N Karam; Chad M Warren; Marcus Henze; Natasha H Banke; E Douglas Lewandowski; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-27       Impact factor: 4.733

4.  Impact of site-specific phosphorylation of protein kinase A sites Ser23 and Ser24 of cardiac troponin I in human cardiomyocytes.

Authors:  Paul J M Wijnker; D Brian Foster; Allison L Tsao; Aisha H Frazier; Cristobal G dos Remedios; Anne M Murphy; Ger J M Stienen; Jolanda van der Velden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-09       Impact factor: 4.733

5.  10,000-fold concentration increase of the biomarker cardiac troponin I in a reducing union microfluidic chip using cationic isotachophoresis.

Authors:  Danny Bottenus; Talukder Zaki Jubery; Yexin Ouyang; Wen-Ji Dong; Prashanta Dutta; Cornelius F Ivory
Journal:  Lab Chip       Date:  2011-03-07       Impact factor: 6.799

6.  Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.

Authors:  Weihua Song; Emma Dyer; Daniel J Stuckey; O'Neal Copeland; Man-Ching Leung; Christopher Bayliss; Andrew Messer; Ross Wilkinson; Jordi Lopez Tremoleda; Michael D Schneider; Sian E Harding; Charles S Redwood; Kieran Clarke; Kristen Nowak; Lorenzo Monserrat; Dominic Wells; Steven B Marston
Journal:  J Biol Chem       Date:  2011-05-26       Impact factor: 5.157

7.  Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.

Authors:  Yingcai Wang; Jose Renato Pinto; Raquel Sancho Solis; David Dweck; Jingsheng Liang; Zoraida Diaz-Perez; Ying Ge; Jeffery W Walker; James D Potter
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

8.  Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation.

Authors:  Paul J M Wijnker; Vasco Sequeira; D Brian Foster; Yuejin Li; Cristobal G Dos Remedios; Anne M Murphy; Ger J M Stienen; Jolanda van der Velden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-28       Impact factor: 4.733

9.  Phosphorylation of protein kinase C sites Ser42/44 decreases Ca(2+)-sensitivity and blunts enhanced length-dependent activation in response to protein kinase A in human cardiomyocytes.

Authors:  Paul J M Wijnker; Vasco Sequeira; E Rosalie Witjas-Paalberends; D Brian Foster; Cristobal G dos Remedios; Anne M Murphy; Ger J M Stienen; Jolanda van der Velden
Journal:  Arch Biochem Biophys       Date:  2014-05-09       Impact factor: 4.013

10.  Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice.

Authors:  Laurel A K McKee; Hao Chen; Jessica A Regan; Samantha M Behunin; Jeffery W Walker; John S Walker; John P Konhilas
Journal:  Arch Biochem Biophys       Date:  2013-01-23       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.